AbbVie enters $3.0 billion revolving credit facility maturing in 2030

AbbVie Inc.

On January 30, 2025, AbbVie entered a $3.0 billion unsecured revolving credit agreement with JPMorgan Chase as agent.
The new facility matures on January 30, 2030, and AbbVie had no borrowings outstanding on the effective date.
AbbVie's existing $5.0 billion revolver maturing in March 2028 remains in effect, bringing total revolving capacity to $8.0 billion.
Borrowings under the facility bear variable interest rates and are subject to customary covenants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.